1. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Clin Appl Thromb Hemost. 2018 Jan 1: 1076029618761005.
2. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Arq Bras Cardiol. 2018 Mar 12; 110(4):333-338.
3. The relationship between post-procedural platelet count and left ventricular aneurysm in patients with acute anterior ST-segment elevation myocardial infarction following primary percutaneous coronary intervention. Kardiol Pol. 2018;76(5):899-907.
4. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Kardiol Pol. 2016;74(10):1160-1166.
5. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Acta Cardiol. 2016 Apr;71(2):241-6.
6. Altered Therapeutic Window of Coronary Heart Disease Treatment Drug Clopidogrel in Drug-Induced Cholestasis Patients. Lat. Am. J. Pharm. 2016;35(5A):1269-72.
7. Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction. Exp Ther Med. 2016 Dec;12(6):4147-4153.
8. Risk factors for carotid artery stenosis in chinese patients undergoing coronary artery bypass graft interventions. Medcine 94(28) e1119.